TNFSF11 and breast cancer: Blocking RANKL (Gonzalez-Suarez et al., 2010, Schramek et al., 2010, Joshi et al., 2010) or progesterone-receptor (PgR) pathways (Poole et al., 2006) substantially reduces mammary cancers in mice.